This Government Contract opportunity from Department Of Defense was posted on June 23, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Active Pharmaceutical Ingredient (API) Supply for Valsartan

Closed

Federal

Submission Closed07/23/2026, 07:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325411

New

DIBBS

Lidocaine Hydrochloride Jelly Supply

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Orange Flavored Electrolyte Oral Hydration Powder

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BENZOCAINE AND MENTHOL

Solicitation # SPE2DP-26-T-5007

Solicitation SPE2DP-26-T-5007 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the acquisition of Cepacol Extra Strength Sore Throat Honey Lemon Lozenges. The requirement consists of three packages of oral pain relievers, each containing 16 lozenges with 15mg of Benzocaine and 2.6mg of Menthol, identified by NSN 6505-01-708-1449. The items must be stored between 20-25 degrees Celsius and protected from humidity, with a non-extendable shelf life of 36 months. Delivery is required within 20 days after order, with a required delivery date of September 14, 2026, shipped FOB Destination to Prince Sultan Air Base in Saudi Arabia. Packaging must be commercial and compliant with MIL-STD-2073-1E and RP001, utilizing sealed unit containers to prevent damage. Marking must strictly adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Inspection and acceptance will occur at the destination per FAR 52.246-2. The contractor is required to use the Wide Area WorkFlow system for electronic invoicing and receiving reports. This procurement is governed by NAICS 325411 and includes standard FAR and DFARS clauses regarding the Buy American Act, safeguarding covered defense information, and combating trafficking in persons.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-5016

This contract is for the procurement of fruit punch flavored glucose gel, provided in 1.1oz squeezable pouches and sold in packages of six. The product is fat-free, gluten-free, and designed for energy boosting, with a non-extendable shelf life of 36 months. Storage requirements specify room temperature and prohibit refrigeration, freezing, or exposure to excessive heat and moisture. The order consists of four packages to be delivered to the Naval Health Clinic Quantico in Virginia within 20 days. Compliance is required for DLA packaging and palletization standards, as well as Medical Marking Standard No. 1. The shipment must be sent via traceable means, and the contract adheres to specific technical and quality requirements set forth in the DLA Master List.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

REHYDRATION SALTS FOR

Solicitation # SPE2DP-26-T-4991

Solicitation SPE2DP-26-T-4991, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a request for quotes for orange flavored electrolyte oral rehydration salts. The requirement consists of four packages of 21 gram packets, provided in quantities of 100 per unit, under NSN 6505-01-687-1441. The delivery is specified as FOB Destination with a required delivery date of September 11, 2026, and a delivery window of 20 days after the order. Inspection and acceptance will occur at the destination, specifically for shipment to the USS Tucson SSN 770. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for material marking. Packaging must be commercial and sealed in suitable containers to prevent damage, with palletization following DLA requirement RP001. If the material is deemed hazardous per FED-STD-313, it must follow TQ requirement IP025; otherwise, it must comply with ASTM D3951. The item is classified as a Type I (Code Q) item with a non-extendable shelf life of 36 months. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with the Buy American and Balance of Payments Program.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4997

Solicitation SPE2DP-26-T-4997 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of Lidocaine Hydrochloride 2% mucosal jelly. The requirement consists of two boxes of sterile topical anesthetic, with each box containing ten 11ml single-use prefilled plastic syringes, each providing 220 mg of the substance. The items are identified by NSN 6505-01-707-4169 and are subject to a non-extendable shelf-life requirement of 36 months. Delivery is required within 20 days after the order, with an original required delivery date of May 1, 2025. The shipping terms are FOB Destination, with primary delivery to Camp Pendleton, California, and a bulk break point in Palmerston, Australia. The contractor must adhere to strict packaging and marking standards, including MIL-STD-2073-1E, RP001 for palletization, and Medical Marking Standard No. 1. All items must be packaged in sealed unit containers to prevent damage and labeled according to the Hazard Communication Standard where applicable. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with various FAR and DFARS clauses, including the Buy American and Balance of Payments Program and safeguarding of covered defense information. Quotations for this requirement were due by September 16, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CARD CASUALTY RESPONSE

Solicitation # SPE2DS-26-T-421W

Solicitation SPE2DS-26-T-421W is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of eight Card Casualty Response Documentation Tools, identified by NSN 6515-01-575-2772. These tools are designed for first responders to document initial casualty treatment and consist of 6.5 by 4.25 inch card stock wrapped in clear plastic, featuring a grommet, a 14-inch cable tie for patient attachment, and a unique individual bar code identifier. The items must be delivered to Fort Bragg, North Carolina, within 20 days after receipt of the order, with a required delivery date of September 14, 2026. The contract mandates strict adherence to DLA Master List of Technical and Quality Requirements, ASTM D3951 for packaging, and MIL-STD-129 and Medical Marking Standard No. 1 for labeling. Bidders are required to specify the source and part number being supplied and must provide a complete data package for any alternate parts offered. Evaluation may include a HUBZone price preference. Compliance with the Buy American Act, the Berry Amendment, and DFARS 252.204-7012 for safeguarding covered defense information is required. Invoicing and payment must be processed through the Wide Area WorkFlow system, and inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

PSYLLIUM HYDROPHILIC M

Solicitation # SPE2DP-26-T-4950

Contract SPE2DP-26-T-4950 is a solicitation issued by the Department of Defense Medical Supply Chain Pharmacy FSA for the procurement of Psyllium Hydrophilic Mucilloid with sugar orange flavor. The item is supplied in 12 gram packets, with each packet containing 25 mg of potassium and 5 mg of sodium, provided in packages of 30. The requirement is for one package under NSN 6505017193181, with a specified shelf life of 24 months that is non-extendable. The product is regulated by the FDA and must be marked according to Medical Marking Standard No. 1. The contract specifies delivery to the USS Roosevelt DDG 80 within 20 days of order. All packaging and palletization must adhere to DLA packaging requirements for procurement and MIL-STD-2073-1E, ensuring items are in sealed unit containers to prevent damage. Bidders are required to specify the source and part number, with the reference part number listed as NDC37000-0740-87 from Procter and Gamble Distributing LLC. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4946

Contract SPE2DP-26-T-4946 is a solicitation issued by the Department of Defense, specifically the DLA Troop Support Medical Supply Chain Pharm FSA, for the procurement of Ondansetron Injection, USP. The requirement is for a 2 mg/ml concentration in 2ml single dose vials, with a package size of 25 units per package. The item must have a non-extendable shelf life of 24 months and be stored between 2 and 25 degrees Celsius while being protected from light. Approved part numbers include those from Hikma Pharmaceuticals USA Inc, Pfizer Inc, and American Pharmaceutical Partners. The contract specifies a quantity of one package under NSN 6505015786170, with a required delivery date of July 2, 2025, and a delivery window of 20 days after order. Shipping is FOB destination to the 5th BN 14th Marines in Seal Beach, California, and must be sent via traceable means rather than parcel post. Packaging must adhere to commercial standards, Medical Marking Standard No. 1, and DLA packaging requirements for procurement. The solicitation falls under NAICS code 325411 and requires compliance with the DLA Master List of Technical and Quality Requirements.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

High Char Yield Polymer Resin Development

NASA SBIR/STTR Program

POSTED

DEADLINE

Supplier of Raw Active Pharmaceutical Ingredient (API) – DiazepamThe Defense Logistics Agency, under the Department of Defense, has established a subcontract for the supply of bulk Diazepam Active Pharmaceutical Ingredient. The material must adhere to USP standards to ensure suitability for the formulation of 5 mg tablets. The supplier is required to provide a Certificate of Analysis and necessary regulatory support to maintain compliance. This procurement falls under NAICS code 325411 and was posted on August 11, 2026.

Defense Logistics Agency

POSTED

DEADLINE

Supplier of Active Pharmaceutical Ingredient (API) – Promethazine HydrochlorideThe contract pertains to the supply of USP-grade promethazine hydrochloride active pharmaceutical ingredient for use in the final formulation of a pharmaceutical product, specifically under a subcontract arrangement. The procurement is managed by the Defense Logistics Agency within the Department of Defense, with the NAICS code 325411 indicating classification under pharmaceutical and biological product manufacturing. Although the solicitation number and specific point of contact are not provided, the posting date is August 9, 2026, and the performance location details are unspecified. The API must meet United States Pharmacopeia standards to ensure quality and compliance with regulatory requirements for drug manufacturing. The contract reference number SPE2DX25D8022 and delivery identifier SPE2D926F8075 are linked through the DIBBS system, facilitating tracking and award administration for the supplier.

Defense Logistics Agency

POSTED

about 1 month ago

DEADLINE

N/A

AI Contract Overview

The contract pertains to the supply of bulk Valsartan active pharmaceutical ingredient (API) with comprehensive documentation covering its origin, synthetic pathway, purity levels, and adherence to United States Pharmacopeia standards. All materials must meet stringent quality controls to ensure compliance with regulatory requirements applicable to pharmaceutical manufacturing. The subcontract is issued under the NAICS code 325411, indicating classification within pharmaceutical and medicine manufacturing, and is administered by the Department of Defense through DLA Troop Support. The solicitation was posted on June 23, 2026, with a response deadline of July 23, 2026, at 7:00 PM. While specific delivery locations or point of contact details are not provided, the obligation to deliver fully documented, USP-compliant Valsartan API remains central to the agreement. The nature of the contract implies that the supplier must demonstrate robust validation of manufacturing processes and provide traceability throughout the supply chain to meet defense pharmaceutical procurement standards.